Julia E. Palmer
YOU?
Author Swipe
View article: Monitoring complete hydatidiform molar pregnancies after normalisation of human chorionic gonadotrophin: national retrospective population study
Monitoring complete hydatidiform molar pregnancies after normalisation of human chorionic gonadotrophin: national retrospective population study Open
Objective To provide evidence for a reduced surveillance protocol to detect gestational trophoblastic neoplasia after normalisation of human chorionic gonadotrophin (hCG) levels following uterine evacuation of a complete hydatidiform mole.…
View article: PREDICT-GTN 2: Two-factor streamlined models match FIGO performance in gestational trophoblastic neoplasia
PREDICT-GTN 2: Two-factor streamlined models match FIGO performance in gestational trophoblastic neoplasia Open
Our streamlined models could be used to assess GTN patients and replace FIGO, statistically matching performance. Given the importance of imaging parameters in guiding treatment, M2 and M3 are favoured for ongoing validation. In resource-p…
View article: Factors associated with failed ‘test of cure’ in the NHS Cervical Screening Programme: A retrospective cohort study
Factors associated with failed ‘test of cure’ in the NHS Cervical Screening Programme: A retrospective cohort study Open
Age >51 yrs. and infection with multiple hr-HPV types were predictors of post treatment hr-HPV persistence. Knowledge of HPV genotype both at referral, and following treatment, could allow a more individualised, and patient-centred, approa…
View article: Flat-dose versus weight or body surface area-based methotrexate dosing in low-risk gestational trophoblastic neoplasia
Flat-dose versus weight or body surface area-based methotrexate dosing in low-risk gestational trophoblastic neoplasia Open
In the treatment of LR-GTN, dose individualisation using BSA or weight is not required, and fixed dosing continues to be preferred as the UK standard.
View article: PREDICT‐<scp>GTN</scp>1: Can we improve the<scp>FIGO</scp>scoring system in gestational trophoblastic neoplasia?
PREDICT‐<span>GTN</span>1: Can we improve the<span>FIGO</span>scoring system in gestational trophoblastic neoplasia? Open
Gestational trophoblastic neoplasia (GTN) patients are treated according to the eight‐variable International Federation of Gynaecology and Obstetrics (FIGO) scoring system, that aims to predict first‐line single‐agent chemotherapy resistan…
View article: Computed tomography chest imaging offers no advantage over chest X-ray in the initial assessment of gestational trophoblastic neoplasia
Computed tomography chest imaging offers no advantage over chest X-ray in the initial assessment of gestational trophoblastic neoplasia Open